Skip to Content

FDA Plans to Approve Pfizer Vaccine for Those Aged 12 Years and Older

TUESDAY, May 4, 2021 -- The U.S. Food and Drug Administration plans to expand emergency use of the Pfizer COVID-19 vaccine by next week so that children as young as 12 years can be immunized.

After a Pfizer trial in adolescents showed its vaccine worked as well in teens as it does in adults, the FDA started preparing to add an amendment covering that age group to the vaccine's emergency use authorization, The New York Times reported. Federal officials familiar with the agency's plans who were not authorized to speak publicly relayed the information, The Times said.

Medical experts welcomed the news, calling it a major step forward in the U.S. vaccination campaign. Vaccinating children is key to raising the level of immunity in the population, experts told The Times, and it could put school administrators, teachers, and parents at ease if millions of students become eligible for vaccinations before schools open in September.

Ashish Jha, M.D., dean of the Brown University School of Public Health and the father of two teenage daughters, said the approval would be a big moment for families like his. "It just ends all concerns about being able to have a pretty normal fall for high schoolers," he told The Times. "It's great for them, it's great for schools, for families who have kids in this age range."

While most adolescents seem to be spared from severe COVID-19, Anthony Fauci, M.D., the top COVID-19 adviser to the Biden administration, has stressed the importance of expanding vaccination efforts to include them and even younger children.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Read this next

AI System Can Predict Deterioration in COVID-19 Patients in ED

THURSDAY, May 13, 2021 -- An artificial intelligence (AI) system can predict deterioration of COVID-19 patients in the emergency department, according to a study published online...

Pfizer Vaccine Given Final Approval for Use in Adolescents

THURSDAY, May 13, 2021 -- In a decision that clears the way for schools to reopen safely next fall, U.S. health officials on Wednesday gave their final stamp of approval for the...

Neurological Manifestations Prevalent for Inpatients With COVID-19

THURSDAY, May 13, 2021 -- Neurological manifestations are common among patients hospitalized with COVID-19 and are associated with an increased risk for in-hospital mortality,...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.